• Adial granted inducement equity awards to newly hired Chief Development Officer Matthew Davidson and EVP of Strategy Julie Saiki.
• Davidson received 424,446 restricted stock units, options for 424,447 shares; Saiki received 132,802 restricted stock units, options for 132,802 shares.
• Options carry a USD 2.98 exercise price, set off the June 12 close; 10-year term.
• Portion vests monthly over three years; remaining portion tied to issuance of pre-funded warrants and common warrants under June 11 agreements.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adial Pharmaceuticals Inc. published the original content used to generate this news brief on June 16, 2026, and is solely responsible for the information contained therein.